Cite
Abstract 1836: Combining a novel retinoic acid receptor-γ agonist with immune checkpoint blockade represses lung cancer growth in vivo
MLA
Cheng-Hsin Wei, et al. “Abstract 1836: Combining a Novel Retinoic Acid Receptor-γ Agonist with Immune Checkpoint Blockade Represses Lung Cancer Growth in Vivo.” Cancer Research, vol. 83, Apr. 2023, p. 1836. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8a90ef888d5d82ccddae78966872228b&authtype=sso&custid=ns315887.
APA
Cheng-Hsin Wei, Lu Huang, Blair Kreh, Xiuxia Liu, Liliya Tyutyunyk-Massey, Zibo Chen, Mi Shi, Vidyasagar Vuligonda, Martin Sanders, Serguei Kozlov, King Chan, Amir Horowitz, Mary Carrington, Patrick Hwu, Weiyi Peng, Ethan Dmitrovsky, & Xi Liu. (2023). Abstract 1836: Combining a novel retinoic acid receptor-γ agonist with immune checkpoint blockade represses lung cancer growth in vivo. Cancer Research, 83, 1836.
Chicago
Cheng-Hsin Wei, Lu Huang, Blair Kreh, Xiuxia Liu, Liliya Tyutyunyk-Massey, Zibo Chen, Mi Shi, et al. 2023. “Abstract 1836: Combining a Novel Retinoic Acid Receptor-γ Agonist with Immune Checkpoint Blockade Represses Lung Cancer Growth in Vivo.” Cancer Research 83 (April): 1836. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8a90ef888d5d82ccddae78966872228b&authtype=sso&custid=ns315887.